Publications
5600 Results
- Journal / Conference
- Journal of Clinical Oncology Apr 10;38(11):1126-1137
- Year
- 2020
- Research Committee(s)
- Myeloma
- PMID
- PMID31652094
- PMC
- PMC7145586
- Study Number(s)
- CTSU/E3A06
Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma
- Journal / Conference
- Blood Cancer Journal Feb 13;10(2):17
- Year
- 2020
- Research Committee(s)
- Myeloma
- PMID
- PMID32054831
- PMC
- PMC7018731
- Study Number(s)
- S0777
Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma
- Journal / Conference
- Journal of Clinical Oncology Feb 20;38(6):567-575
- Year
- 2020
- Research Committee(s)
- Melanoma
- PMID
- PMID31880964
- PMC
- PMC7030886
- Study Number(s)
- CTSU/E1609
Phase III Study of Adjuvant Ipilimumab (3 or 10 mg/kg) Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma: North American Intergroup E1609
- Journal / Conference
- American Society for Preventative Oncology annual meeting (March 22-24, 2020, Tucson, AZ), poster
- Year
- 2020
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217
Serological evidence of infections is associated with extent and intensity of intra-prostatic inflammation in men without prostate cancer or indication for biopsy in the placebo arm of the Prostate Cancer Prevention Trial
- Journal / Conference
- International Symposium on Amyloidosis (virtual September 14-18, 2020, Tarragona, Spain), oral, #OP35
- Year
- 2020
- Research Committee(s)
- Myeloma
- Study Number(s)
- S1702
A Phase II Study of Isatuximab (Sar650984) (Nsc-795145) for Patients with Previously Treated Al Amyloidosis (SWOG S1702; NCT#03499808)
- Journal / Conference
- Cancer Epidemiology Biomarkers & Prevention Dec;29(12):2735-2739
- Year
- 2020
- Research Committee(s)
- Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- PMID
- PMID32967863
- PMC
- PMC8195110
- Study Number(s)
- S0000, SWOG-9217
Mendelian randomization analysis of n-6 polyunsaturated fatty acid levels and pancreatic cancer risk
- Journal / Conference
- JNCI Cancer Spectrum, Aug 27;5(1):pkaa074. doi: 10.1093/jncics/pkaa074. eCollection 2021 Feb.
- Year
- 2020
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID33426464
- PMC
- PMC7785047
- Study Number(s)
- CTSU/C80405
IGF-binding proteins, adiponectin and survival in metastatic colorectal cancer: results from CALGB (Alliance)/SWOG 80405
- Journal / Conference
- American Surgical Association Annual Meeting (April 16-18, 2020, Washington, DC), oral presentation
- Year
- 2020
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S1505
SWOG S1505: Initial Surgical Outcome Results from a Randomized Clinical Trial of mFOLFIRINOX vs. Gemcitabine/nab-Paclitaxel for Perioperative Treatment of Resectable Pancreatic Ductal Adenocarcinoma (PDA)
- Journal / Conference
- J Clin Oncol 38, 2020 (suppl 29; abstr 92); ASCO Quality Care Symposium (October 9-10, 2020, Virtual), rapid abstract presentation
- Year
- 2020
- Research Committee(s)
- Cancer Care Delivery
When offered to participate: A systematic review and meta-analysis of patient agreement to participate in cancer clinical trials
- Journal / Conference
- J Clin Oncol 38, 2020 (suppl 29; abstr 126); ASCO Quality Care Symposium (October 9-10, 2020, Virtual), poster
- Year
- 2020
- Research Committee(s)
- Cancer Care Delivery